Ensign Peak Advisors’s Oncorus, Inc. ONCR Stock Holding History

Ensign Peak Advisors’s Portfolio ONCR Stock Details ONCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-38,000	Closed	-$200K	–	2260
2021 Q4	$200K	Sell	38,000 -37,000	-49%	-$286K	﹤0.01%	1927
2021 Q3	$701K	Hold	75,000	–	–	﹤0.01%	1545
2021 Q2	$1.03M	Hold	75,000	–	–	﹤0.01%	1428
2021 Q1	$1.04M	Hold	75,000	–	–	﹤0.01%	1413
2020 Q4	$2.42M	Buy	+75,000	New	+$1.74M	0.01%	956

Other funds holding ONCR

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

Ensign Peak Advisors's ONCR Position: Q1 2022 in Review

Ensign Peak Advisors sold out of Oncorus, Inc. (ONCR) in Q1 2022, closing a stake of 38,000 shares — an estimated $200K sold.

Ensign Peak Advisors first reported a position in ONCR in Q4 2020 and held it in 5 quarters. The position peaked at $2.42M in Q4 2020. 56 funds tracked by Wall St. Rank hold ONCR as of Q1 2022.

Ensign Peak Advisors reported no remaining Oncorus, Inc. position as of Q1 2022 after selling out during the quarter.
Ensign Peak Advisors sold 38,000 Oncorus, Inc. shares in Q1 2022, an estimated $200K.
Ensign Peak Advisors first reported a position in Oncorus, Inc. in Q4 2020 and held it in 5 quarters.
Ensign Peak Advisors's Oncorus, Inc. position peaked at $2.42M in Q4 2020.
56 funds tracked by Wall St. Rank held Oncorus, Inc. as of Q1 2022.

Based on Ensign Peak Advisors's 13F filing for Q1 2022, filed 16 May 2022.